Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future
LaForce, F.M.
Vaccine 29(Suppl 1): A1
2011
ISSN/ISBN: 1873-2518 PMID: 21684419 DOI: 10.1016/j.vaccine.2011.02.077Document Number: 209136
Document emailed within 0-6 h
Related Documents
Jadhav, S.; Gautam, M.; Gairola, S. 2014: Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20(Suppl 5): 37-44John, T.J. 1996: Vaccine stability in the context of vaccine delivery in a developing country: India Developments in Biological Standardization 87: 19-25
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622
Nakada, S. 1987: New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. b. Genetic engineering method using animal cells Nihon Rinsho. Japanese Journal of Clinical Medicine 45(10): 2326-2332
Fine, M. 2004: The Rhode Island influenza vaccine experience 1995-2003: influenza vaccine price, reimbursement, availability, and Rhode Island's influenza vaccination rate Medicine and Health Rhode Island 87(3): 79-80
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Cassetti, M.Cristina.; Katz, J.M.; Wood, J. 2006: Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005 Vaccine 24(5): 541-543
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480
Ford, A.Q.; Touchette, N.; Hall, B.Fenton.; Hwang, A.; Hombach, J. 2016: Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery Vaccine 34(13): 1489-1495
2013: Global Vaccine Action Plan. Decade of vaccine collaboration Vaccine 31 Suppl. 2: B5-31
2013: Global Vaccine Action Plan. Decade of vaccine collaboration Vaccine 31 Suppl. 2: B5-31
Lasch, E.E.; Abed, Y.; Marcus, O.; Gerichter, C.B.; Melnick, J.L. 1986: Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after Developments in Biological Standardization 65: 137-143
Monti, D.J. 1998: Veterinarians integral in resolving avian influenza incidents, developing vaccine Journal of the American Veterinary Medical Association 212(11): 1686-1687
Suhardono, M.; Ugiyadi, D.; Nurnaeni, I.; Emelia, I. 2011: Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia Vaccine 29(Suppl 1): A22-A25
Esparza, Jé.; Osmanov, S.; Pattou-Markovic, C.; Touré, C.; Chang, M.Louise.; Nixon, S. 2002: Past, present and future of HIV vaccine trials in developing countries Vaccine 20(15): 1897-1898
2008: Is it really time to give up on the hope of finding a preventative HIV vaccine? Experts offer a mixed review of the vaccine's future Aids Alert 23(5): 49-52
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294
Dowdle, W.R.; Wolff, C.; Sanders, R.; Lambert, S.; Best, M. 2004: Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification? Bulletin of the World Health Organization 82(1): 59-62